- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
- Locations
-
- Technische Universität Dresden, NCT/UCC, Early Clinical Trial Unit Dresden, Germany
Clinical trial condition
Lymphoma, B-Cell
Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.
1,618 public trials
340 recruiting studies
Lymphoma, B-Cell trial results
Recruiting
Pola-ZR2P in Previously Untreated DLBCL
NCT06664411
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Navy General Hospital Beijing, Beijing Municipality, China
NCT07078500
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT07126236
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Hospital Universitario Miguel Servet Zaragoza, Aragon, Spain
- Hospital Universitario de Burgos Burgos, Castille and León, Spain
- ICO Badalona Badalona, Catalonia, Spain
- Hospital Universitari Vall d'Hebrón Barcelona, Catalonia, Spain
NCT07124936
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- The Affiliated Tumor Hospital of Guangxi Medical University Nanning, Guangxi, China
Recruiting
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
NCT06792825
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Masonic Cancer Center Minneapolis, Minnesota, United States
NCT05667506
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Children's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
- Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
- Nanfang Hospital Guangzhou, Guangdong, China
Recruiting
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
NCT06375733
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Guangxi Medical University Cancer Hospital&Guangxi Cancer Institute Nanning, China
- Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital Zhengzhou, China
NCT02393157
- Conditions
- Burkitt Lymphoma, CD20+ Lymphoblastic Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- New York Medical College Valhalla, New York, United States
Recruiting
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
NCT06340737
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
- Locations
-
- Stanford University Palo Alto, California, United States